We are live on ! Find out more
MD icon

Pediatrix Medical

320 hedge funds and large institutions have $4.14B invested in Pediatrix Medical in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 109 increasing their positions, 117 reducing their positions, and 42 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more call options, than puts

Call options by funds: $5.45M | Put options by funds: $4.88M

6% more capital invested

Capital invested by funds: $3.91B → $4.14B (+$232M)

5% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 42

0.61% less ownership

Funds ownership: 95.5%94.89% (-0.61%)

1% less funds holding

Funds holding: 322320 (-2)

7% less repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 117

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
320
Holders Change
-2
Holders Change %
-0.62%
% of All Funds
7.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
44
Increased
109
Reduced
117
Closed
42
Calls
$5.45M
Puts
$4.88M
Net Calls
+$578K
Net Calls Change
-$3.93M
Name Holding Trade Value Shares
Change
Change in
Stake
WG
126
Winton Group
United Kingdom
$2.12M +$2.09M +45,520 New
LSV Asset Management
127
LSV Asset Management
Illinois
$2.1M +$2.07M +45,100 New
GC
128
Guggenheim Capital
Illinois
$2.06M +$1.51M +32,797 +288%
SCM
129
Sterling Capital Management
North Carolina
$2.05M +$69.3K +1,510 +4%
Treasurer of the State of North Carolina
130
Treasurer of the State of North Carolina
North Carolina
$2.05M +$673K +14,659 +50%
AIM
131
Assured Investment Management
New York
$2.02M -$2.18M -47,450 -52%
SRAM
132
Stone Ridge Asset Management
New York
$1.99M +$274K +5,960 +16%
Squarepoint
133
Squarepoint
New York
$1.96M -$1.8M -39,233 -48%
Pacer Advisors
134
Pacer Advisors
Pennsylvania
$1.94M +$403K +8,782 +27%
WBC
135
Westpac Banking Corp
Australia
$1.87M
PAM
136
Panagora Asset Management
Massachusetts
$1.79M +$1.6M +34,812 +1,006%
OPERF
137
Oregon Public Employees Retirement Fund
Oregon
$1.73M +$21.4K +466 +1%
QT
138
Quantbot Technologies
New York
$1.71M -$1.89M -41,108 -53%
UBS Group
139
UBS Group
Switzerland
$1.7M +$572K +12,458 +52%
Citigroup
140
Citigroup
New York
$1.7M +$819K +17,843 +96%
SOMRS
141
State of Michigan Retirement System
Michigan
$1.61M -$9.18K -200 -0.6%
ERSOT
142
Employees Retirement System of Texas
Texas
$1.59M +$1.56M +34,000 New
IA
143
Icon Advisers
Colorado
$1.57M +$1.54M +33,600 New
ACI
144
AMP Capital Investors
Australia
$1.5M
Nisa Investment Advisors
145
Nisa Investment Advisors
Missouri
$1.5M
RCM
146
Riverhead Capital Management
Delaware
$1.49M -$906K -19,741 -38%
Natixis Advisors
147
Natixis Advisors
Massachusetts
$1.49M +$149K +3,244 +11%
Allianz Asset Management
148
Allianz Asset Management
Germany
$1.45M -$5.32M -115,837 -79%
SFM
149
Systematic Financial Management
New Jersey
$1.4M -$6.66K -145 -0.5%
USAA
150
United Services Automobile Association
Texas
$1.32M +$63.4K +1,380 +5%

MD Hedge Fund Activity: Q3 2018 in Review

320 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Pediatrix Medical (MD) for Q3 2018, worth a combined $4.14B — up 5.9% from $3.91B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new MD positions and 42 closed out — a net gain of 2 holders — while 109 added to existing stakes and 117 trimmed.

The largest buyer was Pzena Investment Management, adding an estimated $43.8M. The largest seller was Thompson Siegel & Walmsley, cutting an estimated $64.8M.

  • 320 institutional investors held Pediatrix Medical (MD) as of Q3 2018, down from 322 in Q2 2018.
  • Funds reported $4.14B of Pediatrix Medical stock for Q3 2018, up 5.9% quarter-over-quarter.
  • 44 funds opened new Pediatrix Medical positions in Q3 2018 and 42 closed out, a net change of +2 holders.
  • The largest Pediatrix Medical buyer in Q3 2018 was Pzena Investment Management, an estimated $43.8M added.
  • The largest Pediatrix Medical seller in Q3 2018 was Thompson Siegel & Walmsley, an estimated $64.8M sold.

Based on aggregated 13F filings for Q3 2018.